Bristol-Myers Squibb Company to Highlight Strong Pipeline and Execution of BioPharma Strategy in Meeting with Investment Community

NEW YORK--(BUSINESS WIRE)--During a meeting with the investment community today, Bristol-Myers Squibb Company (NYSE:BMY) will provide a comprehensive business overview, highlight positive pipeline developments and provide 2013 minimum non-GAAP earnings per share guidance.

MORE ON THIS TOPIC